Vimarsana
Biggest News Aggregation in the World

Monarch 3 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Monarch 3. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Monarch 3 Today - Breaking & Trending Today

Ribociclib/ET versus Chemotherapy in Premenopausal Patients: RIGHT Choice - Vimarsana News

Ribociclib/ET versus Chemotherapy in Premenopausal Patients: RIGHT Choice

Published: August 1, 2023

Timothy Pluard, MD, discusses recent data from an age-based subgroup analysis of RIGHT Choice, which compares the efficacy of combination ribociclib/ET versus chemotherapy in the first-line treatment of HR+/HER2- advanced breast cancer.

Source: onclive.com
Related Topics:
Timothy PluardKomal JhaveriHr Her2 Breast CancerReal World DataCdk4 6 InhibitorsAromatase InhibitorsMonarch 3Polaris TrialRight Choice TrialSerena 6
Real-World Data on CDK4/6 Inhibitors in HR+/HER2- Metastatic Breast Cancer and Ongoing Trials - Vimarsana News

Real-World Data on CDK4/6 Inhibitors in HR+/HER2- Metastatic Breast Cancer and Ongoing Trials

Published: July 25, 2023

Experts on HR+/HER2- breast cancer review recent real-world data on CDK4/6 inhibitors and share excitement about first-line trials that have not yet read out.

Source: onclive.com
Related Topics:
Aditya BardiaGregory VidalKomal JhaveriHr Her2 Breast CancerReal World DataCdk4 6 InhibitorsMonarch 3Polaris TrialRight Choice TrialOral SerdsSerena 6Aromatase Inhibitors